Bioline Rx | BLRX - Current Liabilities

Bioline Rx reported $8.13M in Current Liabilities for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview
Current Liabilities Change
Bio Path BPTH:US USD 2.2M 880K
Bioline Rx BLRX:US USD 8.13M 1.5M
Bluebird Bio BLUE:US USD 126.73M 22.13M
Idera Pharmaceuticals IDRA:US USD 19.23M 14.5M